SARS-CoV-2 M <sup>pro</sup> inhibitors with antiviral activity in a transgenic mouse modelJingxin Qiao, Shengyong Yang, Yueshan Li et al.|Science|2021Cited by 449
SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral targetBingqing Xia, Zhaobing Gao, Feng‐Liang Liu et al.|Cell Research|2021Cited by 198